Roflumilast Tablets (986a85d7 Bfd2 4b9d 85b7 D7e6f9f669fe 01)
Roflumilast Tablet
Product Images NDC 68382-624
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 68382-624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Roflumilast Tablets (986a85d7 Bfd2 4b9d 85b7 D7e6f9f669fe 02)
This appears to be a chart or table showing the impact of certain drugs on the effectiveness of Roflumilast and Roflumilast N-oxide. The chart lists various drugs and whether they require caution when used in combination with Roflumilast, as well as whether they require a dose adjustment or are not recommended altogether. The chart also includes information about the fold change in Cmax and AUC relative to reference.*
Roflumilast Tablets (986a85d7 Bfd2 4b9d 85b7 D7e6f9f669fe 03)
This is a pharmaceutical label for Roflumilast tablets containing 30 tablets with a recommended adult dosage of one tablet (500 mcg) to be taken orally once in a day. It comes in a child-resistant package and must be stored between 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). The medication guide is provided separately to each patient by the pharmacist, and they are available at i-zydususa.com/medguides or by calling 1-677-993-8779. This medication is distributed in the USA by Zydus Pharmaceuticals (USA) Inc, Penringion, NJ 08534.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
